RecallRadar

FDA Drug recall D-0038-2027

Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054

On 2026-10-21 the FDA classified a Class II recall of Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054 by Teva Pharmaceuticals Usa, citing presence of Foreign Tablets/Capsules.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0038-2027
ClassificationClass II
Statusongoing
Initiated2026-09-29
Published2026-10-21
Last updated2026-10-27 05:30 UTC
CompanyTeva Pharmaceuticals Usa
DistributionUS

Product

Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05

Reason

Presence of Foreign Tablets/Capsules

Identifiers

ndc0093-2204-01
ndc0093-2204-05
ndc0093-2203-01
ndc0093-2203-05
ndc0093-2203-10
code_infoLot, expiry: [100 Tablets] Lots 8634085, 8635085, 8636085, exp 07/2027; [500 Tablets] Lot 8633085, exp 07/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-10-27 05:30 UTC. Current status: ongoing.

Other recalls by Teva Pharmaceuticals Usa

All Teva Pharmaceuticals Usa recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0038-2027%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.